Library

A Current Look at the State of Inequitable Conduct and Other Equitable Concerns
Tom Irving, Partner, Marbury Law, USA
AI and Inventorship
Anagha Tendulkar, In-house Patent Counsel, Cipla, India
Amazon v. Donald J. Trump: A Massive Defense Contract Award Tainted by the Appearance of Impropriety
Rodney Sweetland, Vice President and General Counsel, Camris International Inc., USA
Anatomy of a Deal: Good Things Come in Small (and Very Complicated) Packages
Andrew Mayer, Vice President, Legal, Acorda Therapeutics Inc., USA
Jane Wasman, President, International & General Counsel, Acorda Therapeutics Inc., USA
Avoiding Death by Governance: Taking the Governance, Risk and Compliance Frameworks to the next level
John Cowell, General Counsel & Company Secretary, Healthdirect Australia, Australia
Being not Just a General Counsel but also a Commercial Advisor
Viola Teppati, Corporate Lawyer and Key Account Manager, Contrad Swiss SA, Switzerland
Benefits of a Global Mindset to the Administrative Backbone of an Intellectual Property Department
Maja Schmitt, Head of Global Administration, DSM , Netherlands
Brazilian Data Protection Law and its first Impacts
Mariana Silveira Bueno, Legal Manager & DPO, Mindray do Brasil, Brazil
Brexit: The In-House Counsel as Change Catalyst
Miriam Caley, Head of Legal - Ireland, Optum , Ireland
Clare O’Hare, Associate General Counsel, University of Notre Dame, Ireland
Collaborative Privacy and Security Programs and the Symbiosis They Can Create
Marilyn Hanzal, Associate General Counsel, The University of Chicago Medical Center, USA
Compliance Red Flags: What Companies Should Look Out For in Times of Change
Fabiana Lacerca-Allen, SVP Compliance, Aimmune Therapeutics, USA
Tatiyana Akers, Corporate Compliance Consultant, Independent Consultant, USA
Laura Hamm, Director, Corporate Compliance, Aimmune Therapeutics, USA
Brenda Crabtree, Associate Director, Compliance Auditing and Monitoring, Aimmune Therapeutics, USA
Covid19 and the new Role of Legal and Compliance
Fabio Cunha, General Counsel, Legal and Compliance Director, DASA, Brazil
Creative Claiming Strategies
Stacy Lewis, Law Clerk, Finnegan, USA
Angela Sebor, Director Intellectual Property, Tolmar, Inc., USA
Xiaoguang Michelle Gao, Associate VP - Assistant General Patent Counsel , Eli Lilly and Company, USA
Developing Effective Processes to Manage Risk in M&A Transactions
Derek Devgun, Senior Legal Specialist - M&A, Medtronic, Inc., USA
Different Approaches to Pricing and Reimbursement of Innovative Pharmaceutical Products in Europe
Renato Dellamano, President, Value Vector, Italy
Getting Your Staff to Use Trademarks Properly and Effectively
Gabrielle Holley, Shareholder, Holley & Menker, P.A., USA
April Wurster, Patent Attorney, ViaCyte, USA
Liz Bui, Vice President and Intellectual Property Counsel, ViaCyte, USA
Here We Go Again: Has the European Court of Justice revived the cross-border patent injunction?
Paul Coletti, Associate Patent Counsel, Johnson & Johnson Company, USA
Implementing a Robust Compliance Program in a Remote Environment
Fabiana Lacerca-Allen, SVP Compliance, Aimmune Therapeutics, USA
Tatiyana Akers, Associate Director, Compliance, Aimmune Therapeutics, USA
Laura Hamm, Sr. Director, Corporate Compliance, Aimmune Therapeutics, USA
Brenda Crabtree, Associate Director, Compliance Auditing and Monitoring, Aimmune Therapeutics, USA
In-House Counsel as Ethical Leaders
Marion Hemphill, General Counsel , Australian Red Cross Blood Service, Australia
In-house Counsel’s Role in Responding to a Data Privacy Breach
Marion Hemphill, General Counsel , Australian Red Cross Blood Service, Australia
Innovative Programs in Technology Transfer: An Overview of Cedars-Sinai’s Technology Transfer International Program and Its Complementary Diagnostic Development Unit, 3rd Street Diagnostics
James Lau, Vice President for Legal & Technology Affairs, Cedars-Sinai Medical Center, USA
Nirdesh K. Gupta, Director – IP Portfolio Management & Licensing, Technology Transfer, Cedars-Sinai Medical Center, USA
Kristin Martinez, CCRP, Manager, International Relations, Cedars-Sinai Medical Center, USA
Alexander Chai, Assistant Legal Counsel, Cedars-Sinai Medical Center, USA
Invasion of Privacy in the Context of an Investigation: Does it Render Evidence Inadmissible in Canadian Civil Proceedings?
Tamara Hunter, Associate Counsel, DLA Piper (Canada) LLP, Canada
Alexis Kerr, General Counsel, Fraser Health Authority, Canada
Keeping Pace: Updating Your Code of Ethics for the 21st Century Economy
Christopher White, General Counsel & COO, AdvaMed, USA
Legal Recommendations Regarding Labor and Commercial Law Legal Operations in Spain
Isaac Millán, Partner, Quirón Salud, Spain
Enrique Ceca, Partner, Ceca Magán Abogados, Spain
Managing Global Conflict, an overview of the challenges confronting global businesses in the physical security of people, information and assets
Walt Linscott, General Counsel and Secretary, Carestream Health, Inc., USA
Needs, Challenges, and Obstacles in the Implementation of the EU Medical Device Regulation
Tancredi Vergani, Consultant, Obelis Group, Belgium
Carlos Francisco Marin Barrios , Consultant, Obelis Group, Belgium
Optimising Value from the In-house Legal Function
Claudine Boast, Commercial Counsel, Spectris plc, UK
Regulatory Compliance in a Multi-National Organization
Jack Sorokin, Deputy General Counsel (Retired), Beckman Coulter, Inc, USA
REMS Patents: Listability and Other Issues
Tom Irving, Law Clerk, Marbury Law, USA
Stacy Lewis, Law Clerk, Finnegan, USA
Mark Feldstein, Partner, Finnegan, USA
Adriana Burgy, , Finnegan, USA
Joanna Brougher, Owner & Principal, BioPharma Law Group PLLC, USA
Smart Contracts – Self-Executing Contracts of the Future?
Jelena Madir, General Counsel, Gavi, the Vaccine Alliance, Switzerland
Social Accountability and Tax-Exempt Senior Healthcare Care Providers
David Grant, Senior Vice President and General Counsel, American Baptist Homes of the West, USA
Tears and Cheers - Preliminary Legal Analysis on Patient Groups in China
Xiangjun Kong, Head of Strategic Partnership (Previously Head of Legal), Sanofi China, China
The “Ethics” of the Corrupt
Howard Snoyman, Head: Legal and Ethics, Discovery Health Medical Scheme, South Africa
The AstraZeneca Competition Case: Patent Strategies Constituting Abuse of Dominance
Bart Goddyn, Legal Counsel, TiGenix through GODDYN BVBA, Belgium
The Misuse of the FCA to Enforce cGMP (Current Good Manufacturing Practice) Violations
Kyle Faget, Clinical Compliance Counsel, Boston Scientific Corporation, USA
The Pros and Cons of Hiring Independent Contractors in an Era of Regulatory Change
Katharine Dunn, Corporate Counsel, Rising Medical Solutions, LLC, USA
Watching the Dominoes Fall - A Case Study in Preparedness for Increased Regulation in the Cosmetics Industry
Brian Foley, Vice President and General Counsel, NeoStrata Company , Inc., USA
What Makes a Great Compliance Leader?
Lisa Mares, Executive Assistant, Compliance, Aimmune Therapeutics, Inc., USA
Laura Hamm, Director, Corporate Compliance, Aimmune Therapeutics, USA
Brenda Crabtree, Associate Director, Compliance Auditing and Monitoring, Aimmune Therapeutics, USA
Fabiana Lacerca-Allen, SVP Compliance, Aimmune Therapeutics, USA